Study Details

Healthy Non-Smoking Adults Needed

Study Number

8409-184

Group

9

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Feb. 09 - Jun. 15, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

  • Healthy Non-Smoking Adults, age 18-65
  • BMI (body mass index) 18-30
  • Join us for a stay of 8 nights followed by 11 outpatient visits 
  • Compensation up to $7658 may be provided for time and participation

Details

Screening: Jan 13, 14, 15, 16, 21, 23, 29, 30

Check-in: Feb 9, 2020

Check-out: Feb 17, 2020

Outpatient Visits: Feb 20, 24; Mar 2, 9, 23; Apr 6, 20; May 4, 18; June 1, 15

Study Number

8409-184

Group

9

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Feb. 09 - Jun. 15, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

  • Healthy Non-Smoking Adults, age 18-65
  • BMI (body mass index) 18-30
  • Join us for a stay of 8 nights followed by 11 outpatient visits 
  • Compensation up to $7658 may be provided for time and participation

Details

Screening: Jan 13, 14, 15, 16, 21, 23, 29, 30

Check-in: Feb 9, 2020

Check-out: Feb 17, 2020

Outpatient Visits: Feb 20, 24; Mar 2, 9, 23; Apr 6, 20; May 4, 18; June 1, 15

Calculate Your BMI!

Calculate Your BMI!